Lisinopril is NOT Contraindicated in Multiple Sclerosis
Lisinopril has no contraindication related to multiple sclerosis and can be safely used in MS patients who require antihypertensive therapy. The FDA-approved contraindications for lisinopril are limited to: history of ACE inhibitor-related angioedema, hereditary or idiopathic angioedema, hypersensitivity to ACE inhibitors, and co-administration with aliskiren in diabetic patients 1.
Key Clinical Considerations
No MS-Specific Restrictions
- The FDA drug label makes no mention of multiple sclerosis as a contraindication, precaution, or special consideration 1
- MS guidelines focus on disease-modifying therapies and diagnostic criteria, not restrictions on cardiovascular medications 2, 3
- Lisinopril's mechanism (ACE inhibition) does not interfere with MS pathophysiology or disease-modifying treatments
Standard Monitoring Applies
For your 42-year-old MS patient, monitor for the typical lisinopril concerns 1:
- Renal function: Check baseline and periodic creatinine/GFR (especially important if on nephrotoxic MS therapies)
- Potassium levels: Monitor periodically for hyperkalemia
- Blood pressure: Watch for symptomatic hypotension, particularly in the first 2 weeks
- Angioedema: Educate patient on facial/tongue swelling requiring immediate discontinuation
Polypharmacy Awareness
MS patients commonly take multiple medications for symptom management, increasing polypharmacy risk 4. When prescribing lisinopril:
- Review all current medications for drug-drug interactions
- The primary interactions are with diuretics (hypotension risk) and lithium (toxicity risk) 5
- Lisinopril does not interact with common MS disease-modifying therapies
- Consider that MS patients may be on corticosteroids for relapses, which can transiently affect blood pressure
Practical Dosing
- Start with standard dosing: 10 mg once daily for hypertension 1
- Adjust for renal impairment if creatinine clearance ≤30 mL/min 1
- No age-related dose adjustment needed for a 42-year-old patient 1
- Once-daily dosing improves adherence, particularly valuable in patients managing multiple medications
The decision to use lisinopril should be based solely on standard cardiovascular indications and contraindications—MS diagnosis is irrelevant to this choice.